Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 305-769-9 | CAS number: 95009-41-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 02 - 28 Apr 2014
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: see 'Remark'
- Remarks:
- GLP-Guideline study (RL1 is considered appropriate as a) exposure of the animals was performed according to OECD GL 429; b) the used methodology was validated in the test facility according to the performance standards defined in OECD GL 429; c) a publication is included as reference for the validity of the methodology as required according to OECD 429 and d) the threshold used in the study is defined more stringent compared to the threshold provided in the publication)
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- lymphocyte proliferation was measured based on cell counting instead of thymidine incorporation and hence, a different cut off value (EC1.4 instead of EC3) was used for evaluation of results
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- yes
- Remarks:
- lymphocyte proliferation was measured based on cell counting instead of thymidine incorporation and hence, a different cut off value (EC1.4 instead of EC3) was used for evaluation of results
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- (GROUPE INTERMINISTERIEL DES PRODUITS CHIMIQUES)
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- other: CBA/J (CBA/J@Rj)
- Sex:
- female
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Elevage Janvier Labs, Le Genest Saint Isle, France
- Age at study initiation: 8 weeks
- Weight at study initiation: 19.1 - 21.8 g
- Housing: individually housed in suspended solid-floor polypropylene cages furnished with softwood woodflakes
- Diet: A04, SAFE (Augy, France), ad libitum
- Water: tap water from public distribution system, ad libitum
- Acclimation period: at least 5 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 19 - 25
- Humidity (%): 30 - 70
- Air changes (per hr): at least 10
- Photoperiod (hrs dark / hrs light): 12 / 12 - Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 25, 50 and 100%
- No. of animals per dose:
- 4 (+1 additional animal/group as reserve)
- Details on study design:
- RANGE FINDING TESTS:
In a preliminary screening test, the dorsal surface of each ear from 1 mouse was treated daily with 25 µL undiluted test substance for 3 consecutive days. The mouse was observed for signs of toxicity or excessive local irritation. Ear thickness was recorded on Day 1, Day 3 and Day 6. Bodyweight was recorded on Day 1 (prior to dosing) and Day 6. Application of undiluted test substance did not induce clinical signs of systemic toxicity or cutaneous reactions including ear swelling or induction of erythema. Moreover, no irritation was observed due to test substance application. Therefore, no signs indicative for skin irritation were determined and hence, the undiluted test substance was included in the main study as highest concentration.
MAIN STUDY
ANIMAL ASSIGNMENT AND TREATMENT
- Name of test method: lymphocyte cell counting
- Criteria used to consider a positive response: The proliferative response of lymph node cells was expressed as the number of lymphocytes per lymph node and as ratio of lymphocytes of test nodes relative to that recorded for control nodes :
SI = cell count of treated group/cell count of control group
The test item will be regarded as a sensitiser if at least one concentration of the test item results is
greater than 1.4 compared to control values (SI ≥ 1.4) . Other relevant criteria such as dose-response and irritation level were also taken into account for the interpretation of the results. Any test item failing to produce a SI < 1.4 will be classified as a "non-sensitiser".
TREATMENT PREPARATION AND ADMINISTRATION:
25 µL of the test item was applied on the entire dorsal surface of each ear. The application was repeated once daily over 3 consecutive days. Body weights were recored on Day 1 (prior to dosing) and Day 6 (prior to termination). Local irritation reactions were assessed and ear thickness measurements were performed with a micrometer on Day 1 and Day 3 before application and on Day 6 after sacrifice. Furthermore, punch biopsies of both ears were prepared for weighing on Day 6 after sacrifice. The draining auricular lymph nodes of each ear were excised, weighed and pooled for each experimental group. A single cell suspension was prepared by gentle mechanical tissue disaggregation through a 200-meshcell strainers. 10 µL of this cell suspension was diluted in 10 mL of physiological saline solution before lymphocyte cells were counted using a cell counter (Beckman Coulter Z2). A size range of 5 - 15 µm was selected for counting which covers the average size of a lymphocyte of 8 µm. - Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- No significant (SI ≥ 1.4) lymphoproliferative response was noted for the tested concentrations. The calculated stimulation index values were 0.98, 1.02 and 1.32 at test item concentrations of 25%, 50% and 100%, respectively. Thus, as all SI indexes were below 1.4, an EC1.4 value could not be determined.
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: The positive control substance induced a significant lymphoproliferative response as shown by a stimulation index value of 7.3.
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- CLP: non classified
DSD: non classified
Reference
Mortality and clinical signs of toxicity
Application of the test substance did not induce mortaility or clinical signs of systemic toxicity. Body weights of control and test animals were comparable over the study period.
Local skin irritation
No cutaneous reactions were noted during the main test. Dose-dependent increases in ear and lymph node weights were determined which did not result in statistically significant differences. Values obtained for ear thickness were comparable among the groups. Therefore, the test item was not considered as excessively irritant at these concentrations.
Table 2: Cell count. Stimulation index and calculation of EC1.4
Group |
Cell count/group (x 106cells /mL) |
SI |
Control (AOO) |
36.02 |
|
25% |
35.34 |
0.98 |
50% |
36.66 |
1.02 |
100% |
47.38 |
1.32 |
Table 3: Individual ear thickness
Group |
Ear thickness (mm) |
Increase in ear thickness (%) |
Increase in ear thickness (%) |
||
Day 1 |
Day 3 |
Day 6 |
D3/D1 |
D6/D1 |
|
Control (AOO) |
0.21 |
0.22 |
0.18 |
4.8 |
-14.3 |
0.21 |
0.22 |
0.20 |
4.8 |
-4.8 |
|
0.23 |
0.23 |
0.20 |
0.0 |
-13.0 |
|
0.22 |
0.23 |
0.20 |
3.5 |
-10.3 |
|
Mean |
0.22 ± 0.01 |
0.23 ± 0.01 |
0.20 ± 0.01 |
3.5 ± 2.3 |
-10.3 ± 4.3 |
25 % |
0.20 |
0.21 |
0.21 |
5.0 |
5.0 |
0.23 |
0.23 |
0.19 |
0.0 |
-17.4 |
|
0.23 |
0.23 |
0.19 |
0.0 |
-17.4 |
|
0.23 |
0.23 |
0.20 |
0.0 |
-13.0 |
|
Mean |
0.22 ± 0.02 |
0.23 ± 0.01 |
0.20 ± 0.01 |
1.3 ± 2.5 |
-10.7 ± 10.7 |
50% |
0.21 |
0.21 |
0.19 |
0.0 |
-9.5 |
0.24 |
0.22 |
0.20 |
-8.3 |
-16.7 |
|
0.22 |
0.22 |
0.21 |
0.0 |
-4.5 |
|
0.24 |
0.24 |
0.21 |
0.0 |
-12.5 |
|
Mean |
0.23 ± 0.02 |
0.22 ± 0.01 |
0.20 ± 0.01 |
-2.1 ± 4.2 |
-10.8 ± 5.1 |
100% |
0.24 |
0.22 |
0.21 |
-8.3 |
-12.5 |
0.22 |
0.22 |
0.21 |
0.0 |
-4.5 |
|
0.23 |
0.23 |
0.20 |
0.0 |
-13.0 |
|
0.21 |
0.21 |
0.19 |
0.0 |
-9.5 |
|
Mean |
0.23 ± 0.01 |
0.22 ± 0.01 |
0.20 ± 0.01 |
-2.1 ± 4.2 |
-9.9 ± 3.9 |
Table 4: Individual ear biopsy and lymph node weight
Group |
Ear weight (Day 6 (mg) |
% of control |
Lmph nodes (mg) |
% of control |
Control (AOO) |
27.8 |
|
5.2 |
|
27.9 |
4.8 |
|||
25.8 |
4.9 |
|||
25.9 |
4.5 |
|||
Mean |
26.9 ± 1.2 |
|
4.9 ± 0.3 |
|
25 % |
26.0 |
|
5.4 |
|
27.3 |
6.5 |
|||
29.4 |
4.8 |
|||
26.8 |
4.9 |
|||
Mean |
27.4 ± 1.5 |
2.0 |
5.7 ± 0.7 |
16.3 |
50% |
26.4 |
|
6.4 |
|
30.0 |
6.3 |
|||
27.9 |
5.9 |
|||
31.3 |
5.9 |
|||
Mean |
28.9 ± 2.2 |
7.6 |
6.1 ± 0.3 |
24.5 |
100% |
29.2 |
|
6.8 |
|
32.9 |
6.2 |
|||
30.0 |
6.6 |
|||
28.1 |
5.7 |
|||
Mean |
28.1 ± 2.1 |
11.9 |
6.3 ± 0.5 |
28.6 |
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
- Additional information:
Skin sensitization
Sensitizing properties of Fatty acids, vegetable-oil, esters with dipropylene glycol were determined in a GLP-conducted local lymph node assay performed similar to OECD 429 in female CBA/J (CBA/J@Rj) (4 animals/group) (Richeux, F., 2014). In accordance with OECD 429, which states that “other endpoints for assessment of the number of proliferating cells may be employed provided by the performance standards”, lymphocyte proliferation was determined by cell counting using a cell counter (Beckman Coulter Z2) with a selected size range of 5 – 15 µm in regard to an average size of a lymphocyte of 8 µm. Depending on the implemented methodology, a lab-internal cut-off value of SI ≥ 1.4 was validated for a positive sensitization reaction in accordance to the performance standards defined in OECD 429. As shown by Ehling et al., the cut-off values indicating a sensitization reaction, were lower as the traditional cut-off value of SI ≥ 3. Based on the results of a preliminary test, animals were exposed to 25, 50 and 100% (w/v) test substance diluted in a acetone - olive oil (AOO). Application of the test substance did not induce mortaility or clinical signs of systemic toxicity. Body weights of control and test animals were comparable over the study period. Furthermore, no cutaneous reactions were noted during the main test which may indicate irritation of the skin. Dose-dependent increases in ear and lymph node weights were determined which did not result in statistically significant differences for any dose and are therefore not considered as indicative for a sensitization reaction. Further, lymphoproliferative responses leading to stimulation indices 0.98, 1.02 and 1.32 were determined at test item concentrations of 25%, 50% and 100%, respectively, thereby not exceeding the internal validated cut-off value of SI ≥ 1.4. Moreover, taking into consideration that application of the undiluted test substance (100%) does not induce a SI value exceeding the defined cut off value, the test result does not provide sufficient evidence for classification and Fatty acids, vegetable-oil, esters with dipropylene glycol are therefore not considered as sensitizing.
Justification for selection of skin sensitisation endpoint:
The available information comprises an adequate and reliable study (Klimisch score 1), and is thus sufficient to fulfil the standard information requirements set out in Annex VIII, 8.5, of Regulation (EC) No 1907/2006.
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The available data on skin sensitisation of Fatty acids, vegetable-oil, esters with dipropylene glycol do not meet the criteria for classification according to Regulation (EC) 1272/2008 or Directive 67/548/EEC, and are therefore conclusive but not sufficient for classification.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
